John Erb - Vascular Solutions Independent Chairman of the Board
Chairman
Mr. John L. Erb is an Independent Chairman of the Board of Vascular Solutions, Inc., since May 2011. Mr. Erb has 30 years of experience in the medical device industry. Mr. Erb is Chief Executive Officer of Cardia Access, Inc., a medical device company involved in developing new devices for the treatment of heart disease, a position he has held since February 2007. Mr. Erb has also served as Chief Executive Officer of Harbinger Medical, Inc., a medical device company developing a new diagnostic device for sudden cardiac death, since July 2009. During 2007, Mr. Erb served as Executive Chairman of the Board of CHF Solutions, Inc., a medical device company involved in the development, manufacturing and distribution of devices to treat congestive heart failure. From 2001 through 2006, Mr. Erb was Chief Executive Officer of CHF Solutions, Inc. From 1997 through 2001, Mr. Erb was President and Chief Executive Officer of IntraTherapeutics, Inc., a medical device company involved in the development, manufacturing and distribution of peripheral vascular stents. Previously, Mr. Erb was Vice President of Worldwide Operations for Schneider Worldwide, a division of Pfizer, Inc. Mr. Erb serves as a director of several private companies. With over 30 years of experience in the medical device industry, including 15 years of experience serving as Chief Executive Officer of medical device companies. since 2011.
| Age | 66 |
| Tenure | 13 years |
| Phone | 877 656-4251 |
| Web | www.vasc.com |
Vascular Solutions Management Efficiency
The company has return on total asset (ROA) of 0.13 % which means that it generated a profit of $0.13 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.15 %, meaning that it created $0.15 on every $100 dollars invested by stockholders. Vascular Solutions' management efficiency ratios could be used to measure how well Vascular Solutions manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 867 K in liabilities with Debt to Equity (D/E) ratio of 0.13, which may suggest the company is not taking enough advantage from borrowing. Vascular Solutions has a current ratio of 6.24, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Vascular Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, Vascular Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vascular Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vascular to invest in growth at high rates of return. When we think about Vascular Solutions' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 10 records | CHAIRMAN Age | ||
| Charles Chao | Weibo Corp | 51 | |
| Wing Ho | Emerson Radio | 68 | |
| Franz Humer | Diageo PLC ADR | 69 | |
| John Batchelor | Emerson Radio | 39 | |
| Michael Pruitt | Fresh Grapes LLC | 63 | |
| Martin Barrington | Anheuser Busch Inbev | 68 | |
| Kornelis Storm | Anheuser Busch Inbev | 73 | |
| Javier Ferran | Diageo PLC ADR | 63 | |
| Lionel Choong | Emerson Radio | 52 | |
| WingOn Ho | Emerson Radio | 73 | |
Management Performance
| Return On Equity | 0.15 | |||
| Return On Asset | 0.13 |
Vascular Solutions Leadership Team
Elected by the shareholders, the Vascular Solutions' board of directors comprises two types of representatives: Vascular Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vascular. The board's role is to monitor Vascular Solutions' management team and ensure that shareholders' interests are well served. Vascular Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vascular Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Erb, Independent Chairman of the Board | ||
| Brett Demchuk, Vice President - Product Quality | ||
| Phillip Nalbone, Vice President - Corporate Development | ||
| Brent Binkowski, Sr. VP of Operations | ||
| William Rutstein, Sr. VP of International Sales | ||
| Richard Kramp, Independent Director | ||
| Jorge Saucedo, Independent Director | ||
| Jonathan Hammond, Vice President - Manufacturing Engineering | ||
| Charmaine Sutton, Sr. VP of Operations | ||
| Chad Kugler, Sr. VP of RandD | ||
| Martin Emerson, Independent Director | ||
| Richard Nigon, Independent Director | ||
| James Hennen, CFO and Sr. VP of Fin. | ||
| Susan Christian, Vice President - Sales Operations | ||
| Paul OConnell, Independent Director | ||
| Carrie Powers, VP of Marketing | ||
| Howard Root, Co-Founder, CEO and Director |
Vascular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vascular Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 9.41 % | |||
| Current Valuation | 937.53 M | |||
| Shares Outstanding | 17.57 M | |||
| Shares Owned By Insiders | 3.98 % | |||
| Shares Owned By Institutions | 73.40 % | |||
| Number Of Shares Shorted | 982.09 K | |||
| Price To Earning | 81.18 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Solutions check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Solutions' history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |